LexDanaLexDanabeta
Inventor

DIMITRIOS LIZOS

Inventor
CH

Overview

2→
Patents
2021–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
C07BGeneral methods of organic chemistry13%
Y02ATechnologies for adaptation to climate change13%
PatentTitleYear
12,466,808Aminopyridine derivatives and their use as selective ALK-2 inhibitors202511,160,797Pyridinone derivatives and their use as selective ALK-2 inhibitors2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2025Patents assigned to NOVARTIS AG (2)· patent assignee history
2021–2025Based in CH· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NOVARTIS AG22021–2025
Locations
LocationPatentsSpan
CH22021–2025